Edgewise Therapeutics, Inc. (EWTX)

Edgewise Therapeutics Statistics

Total Valuation

EWTX has a market cap or net worth of $2.36 billion. The enterprise value is $1.75 billion.

Market Cap	2.36B
Enterprise Value	1.75B

Important Dates

The last earnings date was Thursday, November 6, 2025, before market open.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

EWTX has 105.87 million shares outstanding. The number of shares has increased by 17.87% in one year.

Current Share Class	105.87M
Shares Outstanding	105.87M
Shares Change (YoY)	+17.87%
Shares Change (QoQ)	+0.53%
Owned by Insiders (%)	0.57%
Owned by Institutions (%)	64.70%
Float	60.49M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.21
P/TBV Ratio	4.13
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 26.51, with a Debt / Equity ratio of 0.01.

Current Ratio	26.51
Quick Ratio	26.03
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -30.02% and return on invested capital (ROIC) is -21.42%.

Return on Equity (ROE)	-30.02%
Return on Assets (ROA)	-20.66%
Return on Invested Capital (ROIC)	-21.42%
Return on Capital Employed (ROCE)	-32.21%
Revenue Per Employee	n/a
Profits Per Employee	-$1.43M
Employee Count	110
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -29.58% in the last 52 weeks. The beta is 0.30, so EWTX's price volatility has been lower than the market average.

Beta (5Y)	0.30
52-Week Price Change	-29.58%
50-Day Moving Average	16.41
200-Day Moving Average	17.02
Relative Strength Index (RSI)	70.01
Average Volume (20 Days)	1,172,620

Short Selling Information

The latest short interest is 9.51 million, so 8.98% of the outstanding shares have been sold short.

Short Interest	9.51M
Short Previous Month	8.62M
Short % of Shares Out	8.98%
Short % of Float	15.72%
Short Ratio (days to cover)	11.24

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-180.97M
Pretax Income	-157.24M
Net Income	-157.24M
EBITDA	-178.83M
EBIT	-180.97M
Earnings Per Share (EPS)	-$1.57

Balance Sheet

The company has $563.34 million in cash and $4.18 million in debt, giving a net cash position of $559.16 million or $5.28 per share.

Cash & Cash Equivalents	563.34M
Total Debt	4.18M
Net Cash	559.16M
Net Cash Per Share	$5.28
Equity (Book Value)	558.65M
Book Value Per Share	5.28
Working Capital	552.25M

Cash Flow

In the last 12 months, operating cash flow was -$132.18 million and capital expenditures -$457,000, giving a free cash flow of -$132.64 million.

Operating Cash Flow	-132.18M
Capital Expenditures	-457,000
Free Cash Flow	-132.64M
FCF Per Share	-$1.25

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

EWTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-17.87%
Shareholder Yield	-17.87%
Earnings Yield	-6.82%
FCF Yield	-5.75%

Analyst Forecast

The average price target for EWTX is $37.30, which is 67.42% higher than the current price. The consensus rating is "Buy".

Price Target	$37.30
Price Target Difference	67.42%
Analyst Consensus	Buy
Analyst Count	10
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2